Tuesday, June 30, 2026

Lilly launches The Memory Radio Station in Europe

Eli Lilly and Company has introduced a Europe-wide awareness campaign focused on memory, brain health and early signs of Alzheimer’s disease. The initiative launched on 26 June 2026 at Palexpo in Geneva, alongside the European Academy of Neurology Congress.

The campaign, called „The Memory Radio Station“, combines a travelling public radio station with an exhibition. Following its Swiss launch, the format is set to visit several European countries, including Austria, Germany, Italy and Belgium.

GenAI turns personal memories into images

At the centre of the campaign is „Synthetic Memories“, a project by Domestic Data Streamers. Visitors can enter a Memory Radio Booth, share personal memories and connect them with songs linked to meaningful moments. The stories are converted into prompts for generative AI, which creates visual interpretations. Participants review and approve the images before they become part of a growing exhibition archive.

Lilly presents the initiative as a way to bring conversations about memory changes into everyday public settings. The station also includes interactive installations on brain health and educational materials for visitors.

Alzheimer’s awareness in a European context

The campaign comes as neurological conditions gain increasing attention in European healthcare. Alzheimer’s disease is the most common cause of dementia. According to figures cited by Lilly, about 9.5 million people in Europe were affected in 2021, with the number expected to reach 17.5 million by 2050.

A key message is the importance of paying attention to early changes. Lilly notes that initial symptoms are often dismissed as normal ageing. By using memories, music and visual storytelling, the campaign aims to encourage broader discussion of cognitive health and potential warning signs.

Partnership with Domestic Data Streamers

„The Memory Radio Station“ was developed by Lilly in partnership with Domestic Data Streamers. The Barcelona-based collective works across data, storytelling and digital installations. Its „Synthetic Memories“ project won the 2025 Ars Electronica Award for Digital Humanity.

Lilly states that the experience is not a medical or therapeutic intervention and is not designed to diagnose, treat or assess any condition. The company also says personal information is handled under applicable data protection rules, including the GDPR, and is not used for clinical research, commercial profiling or product promotion.